We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Proposes Industry Fees to Pay For New Pharmacovigilance Law
EU Proposes Industry Fees to Pay For New Pharmacovigilance Law
The EU’s new pharmacovigilance law could cost generic drugmakers fees totaling as much as $330,000 for each drug they make to cover postmarketing assessments.